Fish Principal Teresa Lavoie will present “The Promise of Cell and Gene Therapies: Regulatory and Reimbursement Roadblocks” at Xconomy’s Xcelerating Life Sciences New York & Philadelphiadigital event on December 3.
This program is an exclusive forum that unites biopharma executives and industry leaders to discuss relevant trends and biotech developments across Philadelphia, New York, and the surrounding regions. With the presence of large biopharma, emerging startups, medical centers, academic institutions, and financial prowess, NY and Philadelphia are uniquely poised to manage the challenges faced during this unprecedented time. This event will cover how NY is keeping the startup community thriving, how PA is navigating cell and gene therapy business and products while facing the effects of the pandemic, and how local resources are leveraging life sciences growth. Panel details are below.
The Promise of Cell and Gene Therapies: Regulatory and Reimbursement Roadblocks
10:30 AM ET
Moderator:Teresa Lavoie, Principal, Fish & Richardson
Panelists:
- Greg White, Senior Director, Global Market Access Policy - Janssen, Pharmaceutical Companies
- Shankar Musunuri, Chairman of the Board, CEO and Co-founder, Ocugen
- Snehal Naik, Global Regulatory Affair- Advanced Therapies, Janssen R&D
For more information, or to register,click here.